Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder

NCT00191022 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

185

Enrollment

INDUSTRY

Sponsor class

Conditions

Social Phobia

Interventions

DRUG: LY686017
DRUG: paroxetine
DRUG: placebo

Sponsor

Eli Lilly and Company